MyFinsight
Home
Compare
About
Recent SEC Filings
10/2
NIKE, Inc.
(NKE)
10/2
DARDEN RESTAURANTS INC
(DRI)
9/30
CONAGRA BRANDS INC.
(CAG)
9/29
Carnival Corp Ltd.
(CCL)
9/29
URANIUM ENERGY CORP
(UEC)
9/29
COPART INC
(CPRT)
9/24
BLACKBERRY Ltd
(BB)
9/24
PAYCHEX INC
(PAYX)
9/23
GENERAL MILLS INC
(GIS)
9/22
ADOBE INC.
(ADBE)
9/18
KROGER CO
(KR)
10/2
NIKE, Inc.
(NKE)
10/2
DARDEN RESTAURANTS INC
(DRI)
9/30
CONAGRA BRANDS INC.
(CAG)
9/29
Carnival Corp Ltd.
(CCL)
9/29
URANIUM ENERGY CORP
(UEC)
9/29
COPART INC
(CPRT)
9/24
BLACKBERRY Ltd
(BB)
9/24
PAYCHEX INC
(PAYX)
9/23
GENERAL MILLS INC
(GIS)
9/22
ADOBE INC.
(ADBE)
9/18
KROGER CO
(KR)
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
|
Compare
Income Overview
Net Income
-$42,220K
EPS
-$0.38
Unit: Thousand (K) dollars
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Research and development
36,296
31,437
20,835*
28,773
General and administrative
9,000
8,182
8,567*
7,898
Total operating expenses
45,296
39,619
29,401
36,671
Loss from operations
-45,296
-39,619
-29,401*
-36,671
Other income, net
3,804
3,852
3,347*
4,084
Net loss
-41,492
-35,767
-26,055*
-32,587
Unrealized gain on investments
-728
-1,076
-202*
428
Comprehensive loss
-42,220
-36,843
-26,257
-32,159
Basic EPS
-0.38
-0.34
-0.304
-0.33
Diluted EPS
-0.38
-0.34
-0.304
-0.33
Basic Average Shares
108,012,388
105,472,766
86,301,815
98,953,331
Diluted Average Shares
108,012,388
105,472,766
86,301,815
98,953,331
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
ORIC Income Statement Sankey Diagram
Sankey diagram visualizing ORIC income statement for the period
Comprehensive loss
-$42,220K
(-16.06%↓ Y/Y)
Net loss
-$41,492K
(-14.13%↓ Y/Y)
Unrealized gain on
investments
-$728K
(-3209.09%↓ Y/Y)
Other income, net
$3,804K
(40.42%↑ Y/Y)
Loss from operations
-$45,296K
(-15.95%↓ Y/Y)
Total operating
expenses
$45,296K
(15.95%↑ Y/Y)
Research and development
$36,296K
(18.81%↑ Y/Y)
General and
administrative
$9,000K
(5.70%↑ Y/Y)
Buy us a coffee
Oric Pharmaceuticals, Inc. (ORIC)
Oric Pharmaceuticals, Inc. (ORIC)